Axsome therapeutics, inc. (AXSM)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15
Assets
Current assets:
Cash and cash equivalents

197,313

219,966

43,600

53,800

42,600

13,968

15,220

20,351

26,632

34,021

31,673

37,994

45,019

36,618

33,887

38,751

44,078

48,036

Prepaid and other current assets

309

413

594

814

1,134

1,246

723

1,187

1,121

1,278

746

842

1,179

1,380

867

1,164

987

996

Total current assets

197,622

220,379

44,236

54,568

43,759

15,215

15,944

21,539

27,753

35,299

32,419

38,837

46,198

37,999

34,754

39,916

45,065

49,032

Equipment, net

34

30

34

40

40

51

64

68

70

68

79

86

93

100

104

33

25

16

Other assets

143

139

168

168

101

112

117

117

114

187

119

119

119

112

59

57

57

26

Total assets

197,800

220,549

44,439

54,777

43,901

15,379

16,125

21,725

27,939

35,555

32,618

39,042

46,411

38,212

34,918

40,007

45,148

49,076

Liabilities and stockholders? equity
Current liabilities:
Accounts payable

12,191

10,943

9,447

6,137

3,434

3,687

4,167

3,175

3,874

3,435

2,942

4,038

4,740

4,081

3,867

3,035

1,830

1,892

Accrued expenses and other current liabilities

9,339

10,949

8,413

4,777

3,739

3,843

3,387

2,953

2,153

2,679

2,743

2,276

2,535

2,820

2,867

2,068

2,083

739

Loan payable, current portion

4,568

2,602

648

2,155

535

3,291

3,285

3,280

3,275

3,269

2,717

1,895

1,079

269

-

-

-

-

Warrant liability

-

-

-

-

-

-

102

117

118

2,791

-

-

-

-

-

-

-

-

Total current liabilities

26,099

24,494

18,508

13,070

7,709

10,821

10,942

9,525

9,420

12,175

8,403

8,211

8,355

7,170

6,735

5,103

3,913

2,631

Loan payable, long-term

15,544

17,332

19,108

17,424

18,817

3,619

4,440

5,190

5,932

6,663

7,375

8,077

8,775

9,470

-

-

-

-

Total liabilities

41,644

41,827

37,617

30,494

26,527

14,441

15,383

14,716

15,353

18,838

15,779

16,288

17,131

16,641

-

-

-

2,631

Stockholders' equity:
Preferred stock, $0.0001 par value per share (10,000,000 shares authorized, none issued and outstanding at March 31, 2020 and December 31, 2019, respectively)

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

Common stock, $0.0001 par value per share (150,000,000 shares authorized, 37,075,422 and 36,933,217 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively)

3

3

3

3

3

3

2

2

2

2

2

2

2

1

1

1

1

1

Additional paid-in capital

364,532

354,614

157,907

156,232

135,561

108,485

98,693

96,677

93,974

93,299

85,991

85,473

84,914

69,210

68,493

68,020

67,538

66,882

Accumulated deficit

-208,400

-175,895

-151,100

-132,000

-118,190

-107,550

-97,953

-89,671

-81,390

-76,584

-69,154

-62,720

-55,636

-47,641

-40,312

-33,117

-26,305

-20,439

Total stockholders' equity

156,156

178,722

6,822

24,282

17,373

937

742

7,008

12,586

16,717

16,839

22,754

29,280

21,571

28,182

34,904

41,234

46,444

Total liabilities and stockholders' equity

197,800

220,549

44,439

54,777

43,901

15,379

16,125

21,725

27,939

35,555

32,618

39,042

46,411

38,212

34,918

40,007

45,148

49,076